05-23-2350 Galanin, Porcine
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| CAS # | Empirical Formula |
|---|---|
| 88813-36-9 | C₁₄₆H₂₁₃N₄₃O₄₀ |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Peptide Content | Y |
| Peptide Sequence | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala-NH₂ |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 05-23-2350 | 0 |
Documentation
Required Licenses
| Title |
|---|
| PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Yu, L., et al. 2001. Regul. Pept. 101, 179. Merriam, L.A., and Parsons, R.L. 1995. J. Neurophysiol. 73, 1374. Homaidan, F.R. 1991. Proc. Natl. Acad. Sci. USA 88, 8744. Lindskog, S., and Ahren, B. 1991. Eur. J. Pharmacol. 205, 21. Ahren, B., et al. 1988. FEBS Lett. 229, 233. Tatemoto, K., et al. 1983. FEBS Lett. 164, 124. |


